In lung adenocarcinoma patients treated with immune checkpoint inhibitors, those with Gram-positive bacterial pneumonia show higher CD4+ T cell counts and CD4+/CD8+ T ratios than those with Gram-negative infections. The gene discussed is CD4; the disease is lung adenocarcinoma.